Picture of Percheron Therapeutics logo

PER — Percheron Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Antisense Therapeutics Posts HY Net Loss For Period Attributable A$5.3 Mln

Feb 22 (Reuters) - Antisense Therapeutics Ltd  ANP.AX :
    * HY NET LOSS FOR PERIOD ATTRIBUTABLE A$5.3 MILLION

Source text for Eikon:  ID:nASX99Tzcw 
Further company coverage:  ANP.AX 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Percheron Therapeutics

See all news